These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2499950)

  • 21. [The effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on blood coagulation in patients with hemophilia A and in healthy men].
    Blättler W; Jacky E; Müller M; Graf M
    Schweiz Med Wochenschr; 1979 Sep; 109(37):1367-8. PubMed ID: 314661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DDAVP in the treatment of bleeding disorders.
    Salva KM; Kim HC; Nahum K; Fallot PL
    Pharmacotherapy; 1988; 8(2):94-9. PubMed ID: 3041385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP).
    Santiago-Borrero PJ; Casanova R
    Bol Asoc Med P R; 1990 May; 82(5):207-10. PubMed ID: 2115785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with arginine vasopressin (DDAVP) in von Willebrand's disease and mild haemophilia.
    Ockelford PA; Menon NC; Berry EW
    N Z Med J; 1980 Nov; 92(672):375-8. PubMed ID: 6970907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of DDAVP and cryoprecipitate in mild to moderate haemophilia A and von Willebrand's disease.
    Berry EW
    Prog Clin Biol Res; 1990; 324():269-78. PubMed ID: 2106689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild bleeding disorders: review of 120 patients.
    Bolton-Maggs P; Wilkinson LS
    Clin Lab Haematol; 1984; 6(3):247-56. PubMed ID: 6335071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
    Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
    N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.
    Casonato A; Dannhauser D; Pontara E; Bertomoro A; Orazi B; Santarossa L; Zerbinati P; Girolami A
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):549-53. PubMed ID: 8874865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DDAVP-induced changes of factor VIII-related activities and bleeding time in patients with von Willebrand's syndrome.
    Schmitz-Huebner U; Balleisen L; Arends P; Pollmann H; Sutor AH
    Haemostasis; 1980; 9(4):204-13. PubMed ID: 6772527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DDAVP in acquired hemophilia A: case report and review of the literature.
    Mudad R; Kane WH
    Am J Hematol; 1993 Aug; 43(4):295-9. PubMed ID: 8372811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal DDAVP: biological and clinical evaluation in mild factor VIII deficiency.
    Chistolini A; Dragoni F; Ferrari A; La Verde G; Arcieri R; Ege Mohamud A; Mazzucconi MG
    Haemostasis; 1991; 21(5):273-7. PubMed ID: 1806455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-Deamino-8-D-arginine vasopressin in the treatment of non-haemophilic patients with acquired factor VIII inhibitor.
    Muhm M; Grois N; Kier P; Stümpflen A; Kyrle P; Pabinger I; Bettelheim P; Hinterberger W; Lechner K
    Haemostasis; 1990; 20(1):15-20. PubMed ID: 2108912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DDAVP (desmopressin; 1-deamino-cys-8-D-arginine-vasopressin) treatment in children with haemophilia B.
    Ehl S; Severin T; Sutor AH
    Br J Haematol; 2000 Dec; 111(4):1260-2. PubMed ID: 11167773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multimeric composition of factor VIII-related protein following DDAVP infusion in normal subjects and patients with hemophilia A and von Willebrand's disease].
    Takase T; Nishino M; Yasui M; Shima M; Yoshikawa N; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1985 Nov; 48(7):1571-8. PubMed ID: 3937410
    [No Abstract]   [Full Text] [Related]  

  • 35. Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial.
    Mansouritorghabeh H; Shirdel A
    J Thromb Haemost; 2016 Feb; 14(2):336-9. PubMed ID: 26599105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical efficacy of desmopressin in the treatment of mild hemophilia A in children].
    Bai ST; Lu J; Sheng GY; Xu ST; Xie L; Peng S
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Sep; 13(9):715-7. PubMed ID: 21924018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The position of a vasopressin derivative ("DDAVP") in the treatment of haemophilia A (author's transl)].
    Blättler W; Jacky E; Müller M; Graf M; Meili E
    Ther Umsch; 1979 Apr; 36(4):330-3. PubMed ID: 377557
    [No Abstract]   [Full Text] [Related]  

  • 38. DDAVP challenge tests in boys with mild/moderate haemophilia A.
    Revel-Vilk S; Blanchette VS; Sparling C; Stain AM; Carcao MD
    Br J Haematol; 2002 Jun; 117(4):947-51. PubMed ID: 12060135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intravenous administration of deamino-D-arginine-vasopressin (DDAVP) to patients with hemophilia A and von Willebrand's disease].
    Janczarski M; Ruszkowska I; Cetnarowicz H; Lopaciuk S
    Acta Haematol Pol; 1990; 21(1):16-21. PubMed ID: 2260405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desmopressin in moderate hemophilia A patients: a treatment worth considering.
    Loomans JI; Kruip MJHA; Carcao M; Jackson S; van Velzen AS; Peters M; Santagostino E; Platokouki H; Beckers E; Voorberg J; van der Bom JG; Fijnvandraat K;
    Haematologica; 2018 Mar; 103(3):550-557. PubMed ID: 29305412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.